Affimed NV News - AFMD

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Affimed NV AFMD NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.03 1.17% 2.60 2.70 2.55 2.57 2.57 14:13:57
more quote information »

Recent News

Date Time Source Heading
11/08/201906:30GLOBEAffimed Announces Pricing of Public Offering of Common..
11/07/201917:12EDGARReport of Foreign Issuer (6-k)
11/07/201917:02EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/07/201916:11GLOBEAffimed Announces Proposed Public Offering of Common Shares
11/07/201916:01GLOBEAffimed Highlights Progress on NK Cell Engager Collaboration..
10/15/201906:30GLOBEAffimed Reports Progress on Key Clinical Development..
8/28/201905:00GLOBEAffimed to Participate in Investor Conferences in September
8/07/201908:24EDGARReport of Foreign Issuer (6-k)
8/07/201907:30GLOBEAffimed Reports Second Quarter 2019 Financial and..
7/31/201905:00GLOBEAffimed Announces Second Quarter 2019 Financial Results and..
7/01/201905:00GLOBEAffimed Added to the Russell 2000®, 3000® and Microcap..
6/27/201916:20EDGARReport of Foreign Issuer (6-k)
6/24/201905:00GLOBEAffimed Announces Clinical Data Update on Lead Product..
6/12/201905:30GLOBEAffimed to Present Data on AFM13 at the 15th International..
6/04/201916:18EDGARReport of Foreign Issuer (6-k)
6/04/201916:01GLOBEAffimed Announces Annual General Meeting of Shareholders
6/03/201905:00GLOBEIcosagen and AbCheck Announce Five-year Licensing Agreement..
5/29/201905:00GLOBEAffimed to Present at the Jefferies 2019 Healthcare..
5/22/201907:38EDGARReport of Foreign Issuer (6-k)
5/22/201907:30GLOBEAffimed Announces R&D Strategy to Focus on Innate Immunity..
5/16/201905:00GLOBEAffimed Announces First Quarter 2019 Financial Results and..
4/17/201916:12EDGARReport of Foreign Issuer (6-k)
4/17/201916:05GLOBEAffimed Provides Regulatory Update on AFM11 Clinical Program
4/11/201916:36EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
4/09/201907:49EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
4/05/201916:10EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
4/02/201909:20EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
4/01/201908:00GLOBEAffimed Highlights AFM24 Innate Cell Engager Novel Mechanism..
3/27/201907:30GLOBEAffimed Reports 2018 Financial Results and Operational..
3/27/201907:03EDGARAnnual and Transition Report (foreign Private Issuer) (20-f)
3/20/201905:00GLOBEAffimed Announces Full Year 2018 Financial Results..
3/19/201905:00GLOBEAffimed Announces Milestone Payment from Genentech and ROCK®..
2/14/201909:09EDGARAmended Statement of Ownership (sc 13g/a)
2/12/201909:38EDGARSchedule 13g
1/25/201911:33EDGARAmended Statement of Ownership (sc 13g/a)
1/15/201916:34EDGARAmended Statement of Ownership (sc 13g/a)
1/07/201907:03EDGARReport of Foreign Issuer (6-k)
11/28/201800:00GLOBEAffimed to Host Research & Development Day on Friday,..
See more news about this stock »


Your Recent History
NASDAQ
AFMD
Affimed NV
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.